Cargando…

Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department

BACKGROUND: Knowledge about COVID-19 infections is expanding, although knowledge about the disease course and antibody formation in patients with an auto-immune disease or immunodeficiency is not fully unraveled yet. It could be hypothesized that immunodeficient patients, due to immunosuppressive dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guchelaar, Niels A.D., van Laar, Jan A.M., Hermans, Maud A.W., van der Houwen, Tim B., Atmaca, Sibel, van Maaren, Maurits S., Brkic, Zana, van Daele, Paul L.A., Dalm, Virgil A.S.H., van Hagen, P. Martin, Rombach, Saskia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Short communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844355/ https://www.ncbi.nlm.nih.gov/pubmed/33532723 http://dx.doi.org/10.1016/j.jtauto.2021.100084

Ejemplares similares

Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review
por: Bansie, Rakesh D, et al.
Publicado: (2021)

COVID-19 Incidence and Disease Course Among Patients at an Allergy Department
por: van der Aa, Louise E., et al.
Publicado: (2023)

Sandostatin therapy in patients with chronic sarcoidosis
por: Timmermans, Wilhelmina M.C., et al.
Publicado: (2017)

Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
por: Both, Tim, et al.
Publicado: (2017)

Distal renal tubular acidosis in primary Sjögren syndrome
por: Both, Tim, et al.
Publicado: (2012)

Everything you need to know about distal renal tubular acidosis in autoimmune disease
por: Both, Tim, et al.
Publicado: (2014)

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
por: Brkic, Zana, et al.
Publicado: (2013)

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
por: Maria, Naomi I, et al.
Publicado: (2014)

Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis
por: Eurelings, Laura E. M., et al.
Publicado: (2019)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

Macrophage-fibroblast interplay: a target for neuropeptide-based treatment of fibrotic disease?
por: Virakul, Sita, et al.
Publicado: (2012)

Managing Behçet’s disease: An update on current and emerging treatment options
por: van Daele, P LA, et al.
Publicado: (2009)

Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Behçet's disease?
por: van Laar, Jan AM, et al.
Publicado: (2009)

Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis
por: Both, Tim, et al.
Publicado: (2016)

Hemophagocytic Lymphohistiocytosis in Activated PI3K Delta Syndrome: an Illustrative Case Report
por: Zhou, Zijun, et al.
Publicado: (2021)

A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report
por: Hermans, Maud A. W., et al.
Publicado: (2016)

Basophil Activation Test in the prediction of anaphylactic reactions against Hymenoptera venom in patients suffering from Systemic Mastocytosis
por: Rietveld, Mark JA, et al.
Publicado: (2012)

Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2
por: Hermans, Maud A. W., et al.
Publicado: (2021)

Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade(®) to Remsima(®)? An Observational Study
por: Xue, Laixi, et al.
Publicado: (2020)

Somatostatin receptor scintigraphy in sarcoidosis
por: Kamphuis, Lieke SJ, et al.
Publicado: (2011)

Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
por: van der Houwen, Tim, et al.
Publicado: (2020)

Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double‐blind, placebo‐controlled challenge study
por: Hermans, M. A. W., et al.
Publicado: (2018)

Homemade Food Allergen Extracts for Use in Skin Prick Tests in the Diagnosis of IgE-Mediated Food Allergy: A Good Alternative in the Absence of Commercially Available Extracts?
por: Terlouw, Severina, et al.
Publicado: (2022)

Leukocyte toll-like receptor expression in pathergy positive and negative Behçet’s disease patients
por: van der Houwen, Tim B, et al.
Publicado: (2020)

The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency
por: Dalm, Virgil A. S. H., et al.
Publicado: (2015)

Psychological Symptoms in Primary Immunodeficiencies: a Common Comorbidity?
por: Manusama, Olivia R., et al.
Publicado: (2022)

Cytokines in the colon of a patient with Behçet's disease
por: Kappen, Jasper H, et al.
Publicado: (2009)

Soluble Interleukin-2 Receptor/White Blood Cell Ratio Reflects Granulomatous Disease Progression in Common Variable Immune Deficiency
por: van Stigt, Astrid C., et al.
Publicado: (2023)

Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab
por: Stroet, Leonie C., et al.
Publicado: (2021)

Targeted Proteomics Reveals Inflammatory Pathways that Classify Immune Dysregulation in Common Variable Immunodeficiency
por: Berbers, Roos-Marijn, et al.
Publicado: (2020)

Determinants of Serum Immunoglobulin Levels: A Systematic Review and Meta-Analysis
por: Khan, Samer R., et al.
Publicado: (2021)

Japanese Encephalitis Virus in Australia: From Known Known to Known Unknown
por: van den Hurk, Andrew F., et al.
Publicado: (2019)

Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome
por: Huijser, Erika, et al.
Publicado: (2021)

Soluble Interleukin-2 Receptor Is a Promising Serum Biomarker for Granulomatous Disease in Common Variable Immune Deficiency
por: van Stigt, Astrid C., et al.
Publicado: (2021)

Mast Cells in Cardiovascular Disease: From Bench to Bedside
por: Hermans, M. A. W., et al.
Publicado: (2019)

What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review
por: van Stigt, Astrid C., et al.
Publicado: (2020)

An Electronic Health Record Text Mining Tool to Collect Real‐World Drug Treatment Outcomes: A Validation Study in Patients With Metastatic Renal Cell Carcinoma
por: van Laar, Sylvia A., et al.
Publicado: (2020)

Identification of CVID Patients With Defects in Immune Repertoire Formation or Specification
por: van Schouwenburg, Pauline A., et al.
Publicado: (2018)

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
por: Ragamin, Aviël, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mnng0ado2ghqjuomnabl6t8sds